Home » Stocks » BIOT

Biotech Acquisition Company (BIOT)

Stock Price: $9.80 USD -0.04 (-0.41%)
Updated Apr 19, 2021 1:53 PM EDT - Market open
Market Cap 245.00M
Revenue (ttm) n/a
Net Income (ttm) n/a
Shares Out 25.00M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day April 19
Last Price $9.80
Previous Close $9.84
Change ($) -0.04
Change (%) -0.41%
Day's Open 9.71
Day's Range 9.75 - 9.82
Day's Volume 22,016
52-Week Range 9.54 - 9.95

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

NEW YORK, March 15, 2021 /PRNewswire/ -- Biotech Acquisition Company (NASDAQ: BIOTU) (the "Company") announced that, commencing March 18, 2021, holders of the units sold in the Company's initial public ...

Other stocks mentioned: BIOTU
1 month ago - PRNewsWire

New York, NY, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Biotech Acquisition Company (the “Company”) announced today that it has closed its initial public offering of 23,000,000 units, including 3,000,000 units ...

Other stocks mentioned: BIOTU
2 months ago - GlobeNewsWire

New York, NY, Jan. 25, 2021 (GLOBE NEWSWIRE) -- Biotech Acquisition Company (the “Company”), a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acqui...

Other stocks mentioned: BIOTU
2 months ago - GlobeNewsWire

Biotech Acquisition Company, a blank check company formed by CRO and venture investor SPRIM targeting the biotech industry, filed on Thursday with the SEC for an initial public offering.

3 months ago - NASDAQ

Biotech Acquisition Company has filed to go public with an IPO on the NASDAQ.

3 months ago - SEC

About BIOT

Biotech Acquisition is a recently organized blank check company incorporated as a Cayman Islands exempted company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one business. We intend to focus on industries that complement our sponsor and management team’s background as affiliates of SPRIM Global Investments, a leading life science investment firm in the healthcare industry. As such, our target sector is expected to be the healthcare... [Read more...]

Industry
Blank Checks / SPAC
IPO Date
Jan 26, 2021
CEO
Michael Shleifer
Country
United States
Stock Exchange
NASDAQ
Ticker Symbol
BIOT
Full Company Profile